Immunotherapy

Immunotherapy is the only treatment that targets the root cause of allergies, rather than just managing the symptoms. It is tailored to each individual patient based on the results of our allergy tests. Once we identify what the dog, cat, or horse is allergic to, a personalised treatment can be developed to keep the allergy under control. Symptoms are significantly reduced—and in many cases, may be completely eliminated. With a proven efficacy of 75% and an excellent safety profile, immunotherapy is suitable for long-term use. The treatment works by gradually introducing small doses of the allergens, which stimulates the immune system and helps build long-term tolerance. This process not only reduces allergic reactions but also changes the course of the disease itself. Immunotherapy is the only therapy that modifies the underlying allergic condition while also relieving symptoms. Consistent adherence to the treatment plan is essential for success and will lead to faster recovery and long-lasting allergy relief.

Immunotherapy is administered subcutaneously in gradually increasing doses and at progressively longer intervals, until reaching a maintenance dose of 1.0 ml every four weeks.
The treatment begins with a starting dose of 0.2 ml, which is incrementally increased over a 12-week period. Once the maintenance dose of 1.0 ml is reached, it is then administered monthly.

In some patients, this standard schedule may progress too quickly. In such cases, adjustments can be made to slow the dosing regimen to ensure better tolerance and safety.

Because allergy is a chronic condition, immunotherapy must be continued throughout the patient’s lifetime to maintain symptom control and improve quality of life. Each vial of immunotherapy lasts approximately 10 months, after which a new vial is required to continue effective treatment.